Top Section/Ad
Top Section/Ad
Most recent
Naturgy and Zurich fall in secondary market after jumbo blocks
Capital raise and investor selldown follow €3bn raise by Engie on Friday evening
UKPN purchase seen as positive by rating agencies, leads to senior and hybrid upgrades
More articles/Ad
More articles/Ad
More articles
-
Autolus Therapeutics, the UK biopharmaceutical company focused on T cell therapies for cancer, is raising additional capital on the Nasdaq. -
Hipgnosis Songs Fund, a London-listed investment trust focused on music royalties, has closed its latest share sale, raising £75m.
-
Warehouse De Pauw (WDP), the Belgian operator of logistics sites and warehouses, raised €200m in an overnight equity block trade on Wednesday.
-
Dutch biotech firm argenx has tapped equity investors for $1bn (€830.3m) to finance research and development.
-
CDH Investments has pocketed HK$1.81bn ($232.m) after offloading a chunk of shares in Topsports International Holdings, a Chinese sportswear retailer.
-
Ambu, the Danish medical equipment company, has raised Dkr1.3bn ($212m) via the sale of new stock to fund a deleveraging of its balance sheet.
